advertisement
 

  Back to News Research News and Information

Current Research News

    15 November 2017

  1. [New!] Fluctuations in the incidence of type 1 diabetes in the United States from 2001 to 2015: a longitudinal study. Free full text available in HTML and PDF formats.
  2. [New!] Screening for Type 1 Diabetes Risk in Newborns: The Freder1k Pilot Study in Saxony.
  3. [New!] Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients’ Age and Disease Duration. Free full text available in HTML and PDF formats.
  4. [New!] Enterovirus-associated changes in blood transcriptomic profiles of children with genetic susceptibility to type 1 diabetes.
  5. [New!] 25-hydroxyvitamin D, autoantigenic and total antibody concentrations: results from a Danish case-control study of newly diagnosed patients with childhood type 1 diabetes and their healthy siblings.
  6. [New!] Associations between birthweight, gestational age at birth and subsequent type 1 diabetes in children under 12: a retrospective cohort study in England, 1998-2012.
  7. [New!] A novel curcumin derivative for the treatment of diabetic neuropathy.

    8 November 2017

  8. Impact of an Automated Bihormonal Delivery System on Psychosocial Outcomes in Adults with Type 1 Diabetes.
  9. The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults.
  10. Maternal obesity as a risk factor for early childhood type 1 diabetes: a nationwide, prospective, population-based case-control study.
  11. Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort.
  12. Factors Affecting Recruitment of Participants for Studies of Diabetes Technology in Newly Diagnosed Youth with Type 1 Diabetes: A Qualitative Focus Group Study with Parents and Children. Free full text available in HTML and PDF formats.

    1 November 2017

  13. Synthetic beta cells for fusion-mediated dynamic insulin secretion. See also Smart artificial beta cells could lead to new diabetes treatment.
  14. On the etiology of type 1 diabetes: Physiological growth in children impacts disease progression.
  15. Time trends, regional variability and seasonality regarding the incidence of type 1 diabetes mellitus in Romanian children aged 0-14 years, between 1996 and 2015.
  16. Incidence, prevalence, and seasonal onset variation of Addison's disease among persons with type 1 diabetes mellitus: nationwide, matched, cohort studies.

    25 October 2017

  17. Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity.
  18. What End Users and Stakeholders Want From Automated Insulin Delivery Systems.
  19. Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort Study. See also Newly-identified third type of diabetes is being wrongly diagnosed as type 2.
  20. Optical coherence tomography angiography vessel density in children with type 1 diabetes. Free full text available in HTML and PDF formats.
  21. Pre-clinical results in pig-to-non-human primate islet xenotransplantation using anti-CD40 antibody (2C10R4)-based immunosuppression.

    18 October 2017

  22. Low Incidence of End-Stage Renal Disease in Childhood-Onset Type 1 Diabetes Followed for Up to 42 Years.
  23. Acceptability of Implantable Continuous Glucose Monitoring Sensor.
  24. Factors Associated with C-peptide Levels after Diagnosis in Children with Type 1 Diabetes Mellitus. Free full text available in HTML and PDF formats.
  25. Markers influencing the presence of partial clinical remission in patients with newly diagnosed type 1 diabetes.
  26. 12-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia.
  27. Type 1 Diabetes and Impaired Awareness of Hypoglycemia Are Associated with Reduced Brain Gray Matter Volumes. Free full text available in HTML and PDF formats.
  28. Early-Life Nutritional Factors and Mucosal Immunity in the Development of Autoimmune Diabetes.
  29. Coxsackievirus B4 as a Causative Agent of Diabetes Mellitus Type 1: Is There a Role of Inefficiently Treated Drinking Water and Sewage in Virus Spreading?

    10 October 2017

  30. Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children. Free full text available in PDF format. See also The risk of type 1 diabetes not increased by swine flu vaccine Pandemrix.
  31. Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine.
  32. The chromosome 6q22.33 region is associated with age at diagnosis of type 1 diabetes and disease risk in those diagnosed under 5 years of age.
  33. Association of glycemic control with reduced risk of large vessel disease after more than 50 years of type 1 diabetes.

    4 October 2017

  34. The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes.
  35. In Silico Modeling of Minimal Effective Insulin Doses Using the UVA/PADOVA Type 1 Diabetes Simulator.

    27 September 2017

  36. T1D Risk Increased Following Influenza A H1N1 Diagnosis in Children.
  37. Childhood body mass index in relation to subsequent risk of type 1 diabetes-A Danish cohort study.
  38. Beta Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells.
  39. Nitrate induces a type 1 diabetic profile in alligator hatchlings.

    20 September 2017

  40. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
  41. Vitamin D and probiotics supplement use in young children with genetic risk for type 1 diabetes.
  42. Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM-INSULIN randomized trial.
  43. Pandemic influenza diagnosis and subsequent risk of type 1 diabetes. See also Pandemic Flu May Increase Risk of Type 1 Diabetes In Genetically Predisposed Patients.

    13 September 2017

  44. Helicobacter pylori Infection Is Associated with Type 2 Diabetes, Not Type 1 Diabetes: An Updated Meta-Analysis. Free full text available in HTML and PDF formats.
  45. Incidence trends of type 1 diabetes before and after the reunification in children up to 14 years of age in Saxony, Eastern Germany. Free full text available in HTML and PDF formats.
  46. Severe Hypoglycemia-Induced Fatal Cardiac Arrhythmias are Augmented by Diabetes and Attenuated by Recurrent Hypoglycemia.

    6 September 2017

  47. Protective major histocompatibility complex allele prevents type 1 diabetes by shaping the intestinal microbiota early in ontogeny. See also Role Of Gut Bacteria In Averting Type 1 Diabetes.
  48. Improving the Safety and Functionality of an Artificial Pancreas System for Use in Younger Children: Input from Parents and Physicians.
  49. Albuminuria Reduction after High Dose of Vitamin D in Patients with Type 1 Diabetes Mellitus: A Pilot Study. Free full text available in HTML and PDF formats.
  50. Type 1 diabetes incidence and prevalence trends in a cohort of Canadian children and youth..
  51. Excess all-cause mortality before age 30 in childhood onset type 1 diabetes: data from the Brecon Group Cohort in Wales.
  52. Live attenuated enterovirus vaccine (OPV) is not associated with islet autoimmunity in children with genetic susceptibility to type 1 diabetes: prospective cohort study.

    30 August 2017

  53. What End Users and Stakeholders Want From Automated Insulin Delivery Systems.
  54. Closed Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study.
  55. Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial.
  56. Untargeted metabolomic analysis in naturally occurring canine diabetes mellitus identifies similarities to human Type 1 Diabetes.
  57. Venous, Arterialized-Venous, or Capillary Glucose Reference Measurements for the Accuracy Assessment of a Continuous Glucose Monitoring System.

    23 August 2017

  58. Reprogramming human gallbladder cells into insulin-producing β-like cells. Free full text available in HTML and PDF formats.
  59. Efficacy and safety of Biosimilar (SAR342434 insulin lispro) in adults with type 1 diabetes also using insulin glargine-SORELLA 1 study. Free full text available in PDF format. See also Biosimilar of Humalog Shows Non-Inferiority in Type 1 Diabetes.
  60. Attenuated Suppression of Lipolysis Explains Increases in Triglyceride Secretion and Concentration with Basal Insulin Peglispro (BIL) Relative to Insulin Glargine Treatment in Patients with Type 1 Diabetes.
  61. Single Dose Euglycemic Clamp Studies Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between MK-1293 Insulin Glargine and Originator Insulin Glargine (Lantus) in Type 1 Diabetes and Healthy Subjects.
  62. Detection of Islet Cell Immune Reactivity with Low Glycemic Index Foods: Is This a Concern for Type 1 Diabetes? Free full text available in HTML and PDF formats.

    16 August 2017

  63. Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes. Free full text available in PDF format. See also Pioneering type 1 diabetes therapy safe.

    9 August 2017

  64. Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study.
  65. Closed-Loop Control Without Meal Announcement in Type 1 Diabetes.
  66. Efficacy and Safety of Relamorelin in Diabetics with Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
  67. Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism. Free full text available in PDF format. See also Could diabetes spread like mad cow disease?

    2 August 2017

  68. Bolusing frequency and amount impacts glucose control during hybrid closed-loop.
  69. Fog Computing and Edge Computing Architectures for Processing Data From Diabetes Devices Connected to the Medical Internet of Things.
  70. Patterns of Early-Life Gut Microbial Colonization during Human Immune Development: An Ecological Perspective. Free full text available in HTML and PDF formats.

    26 July 2017

  71. Predictors of early renal function decline in adults with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes and the Pittsburgh Epidemiology of Diabetes Complications studies.
  72. Efficacy and safety of Biosimilar (SAR342434 insulin lispro) in adults with type 1 diabetes also using insulin glargine-SORELLA 1 study.
  73. Beyond glycemic control: a cross-over, double-blind, 24 week intervention with liraglutide in type 1 diabetes.

    19 July 2017

  74. Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children.
  75. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol. Free full text available in HTML and PDF formats.
  76. Anti-IL-21 monoclonal antibody combined with liraglutide effectively reverses established hyperglycemia in mouse models of type 1 diabetes.
  77. Nasal Glucagon Fixes Severe Hypoglycemia in Type 1 Diabetes.

    12 July 2017

  78. My Child Is Islet Autoantibody Positive: Impact on Parental Anxiety.
  79. Occupation with grain crops is associated with lower type 1 diabetes incidence: Registry-based case-control study. Free full text available in PDF format.
  80. Overnight Closed Loop Control Improves Glycemic Control in a Multicenter Study of Adults with Type 1 Diabetes.
  81. The Challenges of Achieving Postprandial Glucose Control using Closed-Loop Systems in Patients with Type 1 Diabetes.
  82. Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children. See also Type 1 diabetes risk linked to intestinal viruses.

    28 June 2017

  83. Extensive Assessment of Blood Glucose Monitoring During Postprandial Period and Its Impact on Closed-Loop Performance.
  84. Genetic and Environmental Interactions Modify the Risk of Diabetes-Related Autoimmunity by 6 Years of Age: The TEDDY Study.
  85. Effects of Type 1 Diabetes Risk Alleles on Immune Cell Gene Expression. Free full text available in HTML and PDF formats.
  86. β-Cell Replacement Strategies: The Increasing Need for a “β-Cell Dogma”. Free full text available in HTML and PDF formats.

    21 June 2017

  87. Oral insulin therapy fails to prevent type 1 diabetes, but some see disease delay.
  88. Racial and ethnic differences among children with new-onset autoimmune Type 1 diabetes.
  89. Retinal Ganglion Cell Loss in Children With Type 1 Diabetes Mellitus Without Diabetic Retinopathy.
  90. Seasonality and autoimmune diseases: The contribution of the four seasons to the mosaic of autoimmunity.

    14 June 2017

  91. Stability, Accuracy, and Risk Assessment of a Novel Subcutaneous Glucose Sensor.
  92. Early childhood infections precede development of beta-cell autoimmunity and type 1 diabetes in children with HLA-conferred disease risk.
  93. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.

    7 June 2017

  94. Bioengineering of an Intraabdominal Endocrine Pancreas. Free full text available in PDF format.
  95. 'Artificial Pancreas' Coming Soon for Diabetes Patients.
  96. Closed-Loop Insulin Delivery for Adults with Type 1 Diabetes Undertaking High-Intensity Interval Exercise Versus Moderate-Intensity Exercise: A Randomized, Crossover Study.
  97. Analyzing breath samples of hypoglycemic events in type 1 diabetes patients: towards developing an alternative to diabetes alert dogs.
  98. Clinical Impact of Blood Glucose Monitoring Accuracy: An In-Silico Study.

    31 May 2017

  99. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials.
  100. "It is Definitely a Game Changer": A Qualitative Study of Experiences with In-home Overnight Closed-Loop Technology Among Adults with Type 1 Diabetes.
  101. Mortality in type 1 diabetes diagnosed in childhood in Northern Ireland during 1989-2012: A population-based cohort study.
  102. Ketoacidosis at diagnosis of type 1 diabetes: Effect of prospective studies with newborn genetic screening and follow up of risk children.
  103. Markers of immune-mediated inflammation in the brains of young adults and adolescents with type 1 diabetes and fatal diabetic ketoacidosis. Is there a difference?
  104. Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?

    24 May 2017

  105. Development of glucose-responsive 'smart' insulin systems.
  106. Impact of age and antibody type on progression from single to multiple autoantibodies in type 1 diabetes relatives.
  107. Sodium-Glucose Co-transporter-2 Inhibitors and Diabetic Ketoacidosis. An Updated Review of the Literature.

    17 May 2017

  108. Infant Feeding and Risk of Type 1 Diabetes in Two Large Scandinavian Birth Cohorts.
  109. A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach.
  110. Study: Artificial pancreas helps young children better control their diabetes.
  111. The Impact of Diet Wheat Source on the Onset of Type 1 Diabetes Mellitus-Lessons Learned from the Non-Obese Diabetic (NOD) Mouse Model. Free full text available in HTML and PDF formats.
  112. Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline.
  113. Hypoglycemic Effect of Combined Ghrelin and Glucagon Receptor Blockade.
  114. A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes.

    10 May 2017

  115. Fatty acid status in infancy is associated with the risk of type 1 diabetes-associated autoimmunity.
  116. Intraperitoneal Insulin Delivery Provides Superior Glycemic Regulation to Subcutaneous Insulin Delivery in Model Predictive Control-based Fully-automated Artificial Pancreas in Patients with Type 1 Diabetes: A Pilot Study.
  117. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
  118. Heterogeneity of Type 1 Diabetes: The Effect of Ethnicity.

    3 May 2017

  119. Dog Exposure During the First Year of Life and Type 1 Diabetes in Childhood. See also Man's Best Friend Fails to Protect Against Type 1 Diabetes.
  120. Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control.
  121. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
  122. A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes. Free full text available in HTML and PDF formats. See also Predictive tool for children with type 1 diabetes will improve care, avoid complications.
  123. Endocannabinoid system acts as a regulator of immune homeostasis in the gut. Free full text available in HTML and PDF formats. See also Compound in marijuana, chili peppers could reduce gut inflammation in type 1 diabetes.
  124. Circulating unmethylated insulin DNA as a potential non-invasive biomarker of beta cell death in type 1 Diabetes: a review and future prospect. Free full text available in HTML and PDF formats.

    26 April 2017

  125. Can Type 1 diabetes progression be halted? Possible role of high dose vitamin D and omega 3 fatty acids.
  126. Performance of an Artificial Pancreas System for Young Children with Type 1 Diabetes.
  127. Effects of Dapagliflozin on Insulin-requirement, Glucose Excretion, and ß- Hydroxybutyrate levels are not related to Baseline HbA1c in Youth with Type 1 Diabetes.
  128. Psychiatric medication use before and after the onset of type 1 diabetes in children and adolescents: A population-based cohort study.
  129. Xenotransplantation of layer-by-layer encapsulated non-human primate islets with a specified immunosuppressive drug protocol.

    19 April 2017

  130. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012.
  131. Ethnic differences in association of high body mass index with early onset of Type 1 diabetes – Arab ethnicity as case study. Free full text available in HTML and PDF formats.
  132. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
  133. Rotavirus Vaccination and the Risk of Celiac Disease or Type 1 Diabetes in Finnish Children at Early Life.
  134. Metabolomics reveals new metabolic perturbations in children with type 1 diabetes.
  135. Low-calorie sweeteners may allow more glucose to enter fat cells.

    12 April 2017

  136. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. See also ‘Medicinal food’ diet counters onset of type 1 diabetes.
  137. Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY). Free full text available in HTML and PDF formats.
  138. Effect of eicosapentaenoic acid and docosahexaenoic acid supplementation on C-peptide preservation in pregnant women with type-1 diabetes: randomized placebo controlled clinical trial.
  139. Virgin Beta Cells Persist throughout Life at a Neogenic Niche within Pancreatic Islets. See also New source of insulin-producing cells discovered for diabetics, A Brand New Type of Insulin-Producing Cell Has Been Discovered Hiding in the Pancreas, and New type of insulin-producing cell discovered.
  140. Single Retinal Layer Evaluation in Patients with Type 1 Diabetes with No or Early Signs of Diabetic Retinopathy: The First Hint of Neurovascular Crosstalk Damage between Neurons and Capillaries?

    29 March 2017

  141. Worm infestations and development of autoimmunity in children - The ABIS study. Free full text available in HTML and PDF formats.
  142. Duodenal mucosa of patients with type 1 diabetes shows distinctive inflammatory profile and microbiota.
  143. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes.
  144. Monogenic Diabetes accounts for 6.3% of cases referred to 15 Italian pediatric diabetes Centers during 2007-2012.
  145. Biomarker found that could help predict the onset of Type 1 diabetes.

    22 March 2017

  146. Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes. Free full text available in HTML and PDF formats.
  147. An analysis of the survival outcomes of simultaneous pancreas and kidney transplantation compared to live donor kidney transplantation in patients with type 1 diabetes: a UK Transplant Registry study.

    15 March 2017

  148. Vaccinations in early life are not associated with development of islet autoimmunity in type 1 diabetes high-risk children: Results from prospective cohort data.
  149. Use of Wearable Sensors and Biometric Variables in an Artificial Pancreas System. Free full text available in HTML and PDF formats.
  150. Meal Detection and Carbohydrate Estimation Using Continuous Glucose Sensor Data.
  151. Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations. Free full text available in HTML and PDF formats.
  152. Association of Skin Intrinsic Fluorescence with Retinal Microvascular Complications of Long Term Type 1 Diabetes in the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
  153. CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success? Free full text available in HTML and PDF formats.

    8 March 2017

  154. Updated 24-year trend of Type 1 diabetes incidence in children in Poland reveals a sinusoidal pattern and sustained increase.
  155. Using in vivo corneal confocal microscopy to identify diabetic sensorimotor polyneuropathy risk profiles in patients with type 1 diabetes. Free full text available in HTML and PDF formats.
  156. Leptin Levels in Patients with Type 1 Diabetes Mellitus After Fetal Pancreatic Stem Cell Transplant.

    1 March 2017

  157. Fasting-Mimicking Diet Promotes Ngn3-Driven β-Cell Regeneration to Reverse Diabetes. Free full text available in HTML and PDF formats. See also Fasting diet 'regenerates diabetic pancreas'.
  158. Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes. See also City of Hope researchers discover new potential cause of type 1 diabetes and and New Theory About the Cause of Type 1 Diabetes.
  159. An Amperometric Glucose Sensor Integrated Into an Insulin Delivery Cannula: In Vitro and In Vivo Evaluation. Free full text available in HTML and PDF formats.
  160. Pleotropic Acute and Chronic Effects of Leptin to Reverse Type 1 Diabetes.

    22 February 2017

  161. Compensatory Hyperconnectivity in Developing Brains of Young Children With Type 1 Diabetes.
  162. Intralymphatic Injection of Autoantigen in Type 1 Diabetes. See also Injection Into Lymph Nodes May Slow Progression of Type 1 Diabetes.
  163. Type 1 Diabetes Candidate Genes Linked to Pancreatic Islet Cell Inflammation and Beta-Cell Apoptosis. Free full text available in HTML and PDF formats.
  164. Early microvascular retinal changes in optical coherence tomography angiography in patients with type 1 diabetes mellitus.
  165. Efficacy and Safety of Metreleptin Therapy in Patients With Type 1 Diabetes: A Pilot Study.

    15 February 2017

  166. Glucose Driven Changes in Beta Cell Identity Are Important for Function and Possibly Autoimmune Vulnerability during the Progression of Type 1 Diabetes. Free full text available in HTML and PDF formats.
  167. The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies.

    8 February 2017

  168. Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus.
  169. In-vitro evaluation of enteric coated insulin tablets containing absorption enhancer and enzyme inhibitor.

    1 February 2017

  170. Psychosocial effects in parents and children 12 years after newborn genetic screening for type 1 diabetes.
  171. Increase in Pancreatic Proinsulin and Preservation of Beta Cell Mass in Autoantibody Positive Donors prior to Type 1 Diabetes Onset.
  172. Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
  173. Residual beta-cell function in diabetes children followed and diagnosed in the TEDDY study compared to community controls.
  174. Interspecies organogenesis generates autologous functional islets. See also Rat-grown mouse pancreases help reverse diabetes in mice.

    25 January 2017

  175. Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study. Free full text available in HTML and PDF formats. See also New artificial pancreas study shows blood sugar improvements in type 1 diabetes.
  176. Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: an open-label, randomised, crossover, controlled trial.
  177. Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes.
  178. Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs). Free full text available in HTML and PDF formats.
  179. Pro-inflammatory Effects of Hypoglycemia in Humans with or without Diabetes.

    18 January 2017

  180. Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes.
  181. First Infant Formula Type and Risk of Islet Autoimmunity in The Environmental Determinants of Diabetes in the Young (TEDDY) Study.
  182. Diet Quality during Infancy and Early Childhood in Children with and without Risk of Type 1 Diabetes: A DEDIPAC Study. Free full text available in HTML and PDF via link.
  183. Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept.

    11 January 2017

  184. Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity.
  185. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
  186. Is islet transplantation a realistic approach to curing diabetes? Free full text available in HTML and PDF formats.
  187. "Learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus.
  188. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. Free full text available in HTML and PDF formats.

    4 January 2017

  189. Bionic pancreas system successfully controls blood sugar without risk of hypoglycemia reports on Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover tria, previously reported.
  190. Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3. Free full text available in HTML and PDF formats.
  191. The influence of sex on hyperfiltration in patients with uncomplicated type 1 diabetes.
  192. Extending Halogen-based Medicinal Chemistry to Proteins. See also Chemically modified insulin is available more quickly.
  193. Harvard biologist retracts diabetes breakthrough in Cell. See also Retraction Notice to: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation.

[ Current Research News | News from 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]



                 
  Back to News Return to Top

Last Updated: Wednesday November 15, 2017 19:50:17
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2017. Comments and Feedback.